These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 28653849)

  • 21. Virtual screening identification and chemical optimization of substituted 2-arylbenzimidazoles as new non-zinc-binding MMP-2 inhibitors.
    Laghezza A; Luisi G; Caradonna A; Di Pizio A; Piemontese L; Loiodice F; Agamennone M; Tortorella P
    Bioorg Med Chem; 2020 Feb; 28(3):115257. PubMed ID: 31874775
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Receptor-based 3D-QSAR approach to find selectivity features of flexible similar binding sites: case study on MMP-12/MMP-13.
    Hadizadeh F; Shamsara J
    Int J Bioinform Res Appl; 2015; 11(4):326-46. PubMed ID: 26561318
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Kinetic characterization of 4,4'-biphenylsulfonamides as selective non-zinc binding MMP inhibitors.
    Santamaria S; Nuti E; Cercignani G; La Regina G; Silvestri R; Supuran CT; Rossello A
    J Enzyme Inhib Med Chem; 2015 Dec; 30(6):947-54. PubMed ID: 25694065
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Drug Design Inspired by Nature: Crystallographic Detection of an Auto-Tailored Protease Inhibitor Template.
    Gall FM; Hohl D; Frasson D; Wermelinger T; Mittl PRE; Sievers M; Riedl R
    Angew Chem Int Ed Engl; 2019 Mar; 58(12):4051-4055. PubMed ID: 30615822
    [TBL] [Abstract][Full Text] [Related]  

  • 25. N-O-isopropyl sulfonamido-based hydroxamates: design, synthesis and biological evaluation of selective matrix metalloproteinase-13 inhibitors as potential therapeutic agents for osteoarthritis.
    Nuti E; Casalini F; Avramova SI; Santamaria S; Cercignani G; Marinelli L; La Pietra V; Novellino E; Orlandini E; Nencetti S; Tuccinardi T; Martinelli A; Lim NH; Visse R; Nagase H; Rossello A
    J Med Chem; 2009 Aug; 52(15):4757-73. PubMed ID: 19606871
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combined structure- and ligand-based pharmacophore modeling and molecular dynamics simulation studies to identify selective inhibitors of MMP-8.
    Kalva S; Vinod D; Saleena LM
    J Mol Model; 2014 May; 20(5):2191. PubMed ID: 24756550
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of matrix metalloproteinase inhibitors by chemical arrays.
    Kawatani M; Fukushima Y; Kondoh Y; Honda K; Sekine T; Yamaguchi Y; Taniguchi N; Osada H
    Biosci Biotechnol Biochem; 2015; 79(10):1597-602. PubMed ID: 25988721
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Discovery of novel, highly potent, and selective quinazoline-2-carboxamide-based matrix metalloproteinase (MMP)-13 inhibitors without a zinc binding group using a structure-based design approach.
    Nara H; Sato K; Naito T; Mototani H; Oki H; Yamamoto Y; Kuno H; Santou T; Kanzaki N; Terauchi J; Uchikawa O; Kori M
    J Med Chem; 2014 Nov; 57(21):8886-902. PubMed ID: 25264600
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Strategic targeting of multiple water-mediated interactions: a concise and rational structure-based design approach to potent and selective MMP-13 inhibitors.
    Fischer T; Riedl R
    ChemMedChem; 2013 Sep; 8(9):1457-61, 1572. PubMed ID: 23894097
    [No Abstract]   [Full Text] [Related]  

  • 30. Design and synthesis of carboxylate inhibitors for matrix metalloproteinases.
    Fujisawa T; Katakura S; Odake S; Morita Y; Yasuda J; Yasumatsu I; Morikawa T
    Chem Pharm Bull (Tokyo); 2001 Oct; 49(10):1272-9. PubMed ID: 11605653
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Trivalent metal ions based on inorganic compounds with in vitro inhibitory activity of matrix metalloproteinase 13.
    Wen H; Qin Y; Zhong W; Li C; Liu X; Shen Y
    Enzyme Microb Technol; 2016 Oct; 92():9-17. PubMed ID: 27542739
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chemically modified tetracyclines as inhibitors of MMP-2 matrix metalloproteinase: a molecular and structural study.
    Marcial BL; Sousa SF; Barbosa IL; Dos Santos HF; Ramos MJ
    J Phys Chem B; 2012 Nov; 116(46):13644-54. PubMed ID: 23121406
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Matrix metalloproteinase-9 (MMP-9) and its inhibitors in cancer: A minireview.
    Mondal S; Adhikari N; Banerjee S; Amin SA; Jha T
    Eur J Med Chem; 2020 May; 194():112260. PubMed ID: 32224379
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Crystal structures of novel non-peptidic, non-zinc chelating inhibitors bound to MMP-12.
    Morales R; Perrier S; Florent JM; Beltra J; Dufour S; De Mendez I; Manceau P; Tertre A; Moreau F; Compere D; Dublanchet AC; O'Gara M
    J Mol Biol; 2004 Aug; 341(4):1063-76. PubMed ID: 15289103
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fragment-Based Discovery of 5-Arylisatin-Based Inhibitors of Matrix Metalloproteinases 2 and 13.
    Agamennone M; Belov DS; Laghezza A; Ivanov VN; Novoselov AM; Andreev IA; Ratmanova NK; Altieri A; Tortorella P; Kurkin AV
    ChemMedChem; 2016 Sep; 11(17):1892-8. PubMed ID: 27418256
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Design strategies for the identification of MMP-13 and Tace inhibitors.
    Skotnicki JS; DiGrandi MJ; Levin JI
    Curr Opin Drug Discov Devel; 2003 Sep; 6(5):742-59. PubMed ID: 14579524
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pyrimidine-2,4,6-Triones: a new effective and selective class of matrix metalloproteinase inhibitors.
    Grams F; Brandstetter H; D'Alò S; Geppert D; Krell HW; Leinert H; Livi V; Menta E; Oliva A; Zimmermann G; Gram F; Brandstetter H; D'Alò S; Geppert D; Krell HW; Leinert H; Livi VMenta E; Oliva A; Zimmermann G
    Biol Chem; 2001 Aug; 382(8):1277-85. PubMed ID: 11592410
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Design and Structural Evolution of Matrix Metalloproteinase Inhibitors.
    Fischer T; Senn N; Riedl R
    Chemistry; 2019 Jun; 25(34):7960-7980. PubMed ID: 30720221
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Probing the S1' site for the identification of non-zinc-binding MMP-2 inhibitors.
    Di Pizio A; Laghezza A; Tortorella P; Agamennone M
    ChemMedChem; 2013 Sep; 8(9):1475-82, 1421. PubMed ID: 23873724
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of Non-Zinc Binding Inhibitors of MMP-2 Through Virtual Screening and Subsequent Rescoring.
    Shamsara J
    Drug Res (Stuttg); 2018 Sep; 68(9):529-535. PubMed ID: 29614516
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.